| Effects of three different medications on metabolic parameters and testicular volume in patients with hypogonadotropic hypogonadism: 3‐year experience A Aydogdu, E Bolu, A Sonmez, I Tasci, C Haymana, R Acar, C Meric, ... Clinical endocrinology 79 (2), 243-251, 2013 | 16 | 2013 |
| The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study DC Guven, R Acar, E Yekeduz, I Bilgetekin, NK Baytemur, C Erol, ... Current Problems in Cancer 45 (6), 100760, 2021 | 15 | 2021 |
| Individual variations in ankle brachial index measurement among Turkish adults O Demir, I Tasci, C Acikel, K Saglam, M Gezer, R Acar, B Yildiz, F Bulucu, ... Vascular 24 (1), 53-58, 2016 | 13 | 2016 |
| Swords and Shields" against COVID-19 for patients with cancer at "clean" and "pandemic" hospitals: are we ready for the second wave? C Karacin, R Acar, Ö Bal, T Eren, MA Şendur, Y Açıkgöz, N Karadurmus, ... support care cancer, 2021 | 10 | 2021 |
| Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor-1 in patients with end-stage renal disease: associations with laboratory findings … I Erturk, F Yesildal, R Acar, T Ozgurtas, K Saglam Saudi Medical Journal 39 (6), 586, 2018 | 9 | 2018 |
| Association between Beta-Hydroxybutyrate Levels and Survival in Sepsis Patients R Acar, ismail Erturk, G Taskin, M Uyanik, ilker Tasci, BB Basgoz, S Ozer, ... Ejmi 5 (1), 39-44, 2021 | 6 | 2021 |
| Abdominal Obesity is Associated With a Lower Ankle–Brachial Index in Women With Polycystic Ovary Syndrome MI Dogan, I Tasci, F Bulucu, A Aydogdu, R Acar, T Ceyhan, B Koc, ... Angiology 64 (2), 105-111, 2013 | 6 | 2013 |
| Low frequency of a decreased ankle brachial index and associated conditions in the practice of internal medicine in a Turkish population sample. M Gezer, I Tasci, O Demir, C Acikel, M Cakar, K Saglam, F Bulucu, R Acar, ... International Angiology: a Journal of the International Union of Angiology …, 2012 | 6 | 2012 |
| Evaluation of the effects of different treatment modalities on angiogenesis in heart failure patients with reduced/mid-range ejection fraction via VEGF and sVEGFR-1 I Erturk, K Saglam, S Elasan, MB Aykan, R Acar, F Yesildal, FN Aydin, ... Saudi Medical Journal 39 (10), 1028, 2018 | 5 | 2018 |
| Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer M Gürbüz, A Erman, S Abdullah, U Semiha, GD Atike, Ş Süleyman, ... tumori Journal, 2020 | 4 | 2020 |
| Immunotherapy in Geriatric Patients With Advanced Cancer B Yildiz, R Acar EJMO 11, 40.7, 2020 | 4 | 2020 |
| What is the optimal high-dose treatment following autologous stem cell transplantation in relapsed or refractory germ cell cancer: a retrospective comparison of high-dose ICE … B Yildiz, IP Aral, U Balyemez, E Esin, I Erturk, R Acar, N Karadurmus JBUON 25 (2), 1136-1140, 2020 | 4 | 2020 |
| Angiostatin levels in diabetes mellitus patients receiving insulin treatment: associations with laboratory findings, comorbidities, and medications İ Ertürk, E Sertoğlu, F Yeşildal, R Acar, T Özgürtaş, K Sağlam Turkish Journal of Medical Sciences 48 (6), 1192-1199, 2018 | 4 | 2018 |
| Trastuzumab±capecitabine maintenance after the first-line treatment of HER2-positive advanced gastric cancer: retrospective observational real-life data of Turkish Oncology Group M Gürbüz, E Akkuş, A Sakin, S Urvay, AG Demiray, S Şahin, T Şakalar, ... Journal of Gastrointestinal Cancer 53 (2), 282-288, 2022 | 3 | 2022 |
| High-dose Chemotherapy Response in Adults with Relapsed/Refractory Small Round Cell Tumours MB Aykan, I Erturk, R Acar, GS Yildiran, B Yildiz, N Karadurmus Age (mean±SD) 26 (8.57), 29.40-8.98, 2022 | 3 | 2022 |
| Retrospective analysis of long-term survival after combination treatment with gemcitabine, oxaliplatin and paclitaxel in patients with refractory or relapsed testicular cancers İ Ertürk, B Yıldız, N Karadurmuş, B Tosun, R Esen, R Acar, M Urkan, ... Gülhane Tip Dergisi 60 (4), 145, 2018 | 3 | 2018 |
| Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group C Erol, MAN Sendur, I Bilgetekin, DB Garbioglu, J Hamdard, S Akbas, ... Journal of cancer research and therapeutics 18 (Suppl 2), S347-S353, 2022 | 2 | 2022 |
| Trastuzumab+/-Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group M Gurbuz, E Akkus, A Sakin, S Urvay, A Demiray, S Sahin, T Sakalar, ... JOURNAL OF GASTROINTESTINAL CANCER 53 (2), 2022 | 2 | 2022 |
| Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantation I Erturk, N Karadurmus, H Kızıloz, R Acar, B Yildiz, MB Aykan, R Esen, ... Journal of Oncology Pharmacy Practice 27 (7), 1657-1664, 2021 | 2 | 2021 |
| Clinical presentation and course of the novel coronavirus disease 2019 in patients with various types of cancer: A retrospective case–control analysis of an experienced cancer … R ACAR, D Dogan, Y Arslan, C Tasci | 2 | 2021 |
